259.60SEK+0.39%Mkt Cap: 782.17M $P/E: 110.941d ago
Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates…
Indicators:|
Key Statistics
Company
Market Cap782.17M $
Enterprise Value764.43M $
Revenue (TTM)79.82M $
Gross Profit57.34M $
Net Income (TTM)2.41M $
Revenue/Share2.534 USD
Last Price259.60 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees199
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0004840718
Valuation
P/E (Trailing)110.94
P/E (Forward)43.93
PEG—
EV/EBITDA58.24
EV/Revenue9.58
P/S9.80
P/B3.87
EPS (TTM)2.34
EPS (Forward)5.91
52W Range
160.0066% of range310.40
52W High310.40 SEK
52W Low160.00 SEK
Profitability
Gross Margin73.81%
Oper. Margin13.26%
EBITDA Margin16.44%
Profit Margin3.10%
ROE1.19%
ROA1.06%
Growth
Revenue Growth10.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF9.67M $
CapEx (TTM)24.19M $
FCF Margin-10.36%
FCF Yield-1.06%
Net Debt-17.74M $
Net Debt/EBITDA-1.35
Balance Sheet
Debt/Equity0.06
Current Ratio4.52
Quick Ratio3.10
Book Value/Sh67.09 SEK
Cash/Share9.782 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)348.00 SEK
Upside (mean)+34.1%
Target Range310.00 SEK – 385.00 SEK
SEK310.00+34.1% to meanSEK385.00
# Analysts5
Ownership
Shares Out.31.50M
Float25.13M
Insiders7.85%
Institutions61.70%
Technical
SMA 50276.60 (-6.1%)
SMA 200213.52 (+21.6%)
Beta1.44
S&P 52W Chg20.05%
Avg Vol (30d)54.32K
Avg Vol (10d)51.62K
Technical Indicators
RSI (14)44.5
MACD-5.8169
MACD Signal-5.0154
MACD Hist.-0.8016
BB Upper285.70 SEK
BB Middle265.55 SEK
BB Lower245.40 SEK
BB Width15.17%
ATR (14)10.70 SEK
Vol Ratio (20d)1.19x